Intriguingly, CAR T cells harboring CARD11-PIK3R3 exhibited robust target cell elimination, irrespective of IL-2 levels, underscoring their potent anti-tumor activity (Fig. 1B). This evidence concerns the gene IL2 and neoplasm.